Aurobindo Pharma reports 7% fall in Q4 consolidated net profit

31 May 2021 Evaluate

Aurobindo Pharma has reported results for fourth quarter and year ended March 31, 2021.

The company has reported a rise of 21.59% in its net profit at Rs 872.58 crore for the quarter under review as compared to Rs 717.64 crore for the same quarter in the previous year. Total income of the company increased by 15.46% at Rs 4,381.45 crore for Q4FY21 as compared Rs 3,794.89 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported a fall of 7.22% in its net profit attributed to the owners at Rs 801.58 crore for the quarter under review as compared to Rs 864 crore for the same quarter in the previous year. Total income of the company decreased by 1.80% at Rs 6,079.60 crore for Q4FY21 as compared Rs 6,191.02 crore for the corresponding quarter previous year.

For the year ended March 31, 2021, the company has reported a rise of 65.86% in its net profit at Rs 3,112.91 crore as compared to Rs 1,876.88 crore for the previous year. Total income of the company increased by 20.56% at Rs 16,413.54 crore for year under review as compared to Rs 13,614.20 crore for year ended March 31, 2020.

For the year ended March 31, 2021, on the consolidated basis, the company has reported a rise of 87.51% in its net profit attributed to the owners at Rs 5,334.85 crore as compared to Rs 2,845.13 crore for the previous year. Total income of the company increased by 8.50% at Rs 25,155.47 crore for year under review as compared to Rs 23,184.70 crore for year ended March 31, 2020.

Aurobindo Pharma Share Price

1193.70 21.20 (1.81%)
12-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1794.30
Dr. Reddys Lab 1279.65
Cipla 1517.20
Zydus Lifesciences 929.05
Lupin 2114.10
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×